ALICIA (Acalabrutinib in CLL Therapy)

Clinical trial NCT04746950 · COMPLETED

Trial details

NCT number: NCT04746950
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2021-02-03
Primary completion: 2026-02-28
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.